Portfolio company
EnClear Therapies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Carthera
This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.
CereVasc
This medical device company develops a minimally invasive endovascular shunt system to treat patients suffering from communicating hydrocephalus and other neurological brain disorders.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Cordance Medical
This company develops a focused ultrasound device to open the blood-brain barrier for clinicians treating patients with brain tumours and other neurological diseases.
QV Bioelectronics
The company develops implantable bioelectronic devices that deliver electric field therapy to treat patients with aggressive brain tumours.
Reservoir Neuroscience
The company develops therapeutics to repair the blood-brain barrier for patients with age-related neurodegeneration and chronic epilepsy.
Enspiredbstherapy
This company develops an implantable deep brain stimulation system combined with physical therapy to restore arm motor function for stroke recovery patients.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
